🔎 Trials Near Me

Hjem › Myelodysplastiske syndromer › Kansas

Kliniske studier for Myelodysplastiske syndromer i Kansas

5 studier for Myelodysplastiske syndromer søker deltakere på steder i Kansas.

Byer i Kansas

Offisiell studietekst (engelsk)

Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)

  • University of Kansas Clinical Research Center, Fairway
  • University of Kansas Cancer Center, Kansas City
  • University of Kansas Hospital-Westwood Cancer Center, Westwood
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT06577441

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

  • University of Kansas Clinical Research Center, Fairway
  • HaysMed, Hays
  • University of Kansas Cancer Center, Kansas City
  • og 7 flere
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT05564390

A Study of GLB-001 in Patients With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher Risk Myelodysplastic Syndromes

  • University of Kansas Medical Center Research Institute, Inc., Kansas City
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 13. apr. 2026 · NCT06146257

Expanded/Activated Gamma Delta T-cell Infusion Following Hematopoietic Stem Cell Transplantation and Post-transplant Cyclophosphamide

  • University of Kansas Cancer Center, Westwood
RekruttererFase 1
Alder 18 til 65 · Alle kjønn · Oppdatert 25. mar. 2026 · NCT03533816

Study in Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome Patients to Determine the Recommended Dose of CYAD-02

  • University of Kansas Cancer Center, Fairway
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 9. jun. 2020 · NCT04167696

Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.